K, D., D, T., F, E., M, L., M, K., B, R., & H, B. (2013). EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: Folate status during 24 weeks of treatment and over 20 weeks following treatment cessation. International journal of women's health, 5, 149. https://doi.org/10.2147/IJWH.S37254
Chicago Style (17th ed.) CitationK, Diefenbach, Trummer D, Ebert F, Lissy M, Koch M, Rohde B, and Blode H. "EE-drospirenone-levomefolate Calcium Versus EE-drospirenone + Folic Acid: Folate Status During 24 Weeks of Treatment and over 20 Weeks Following Treatment Cessation." International Journal of Women's Health 5 (2013): 149. https://doi.org/10.2147/IJWH.S37254.
MLA (9th ed.) CitationK, Diefenbach, et al. "EE-drospirenone-levomefolate Calcium Versus EE-drospirenone + Folic Acid: Folate Status During 24 Weeks of Treatment and over 20 Weeks Following Treatment Cessation." International Journal of Women's Health, vol. 5, 2013, p. 149, https://doi.org/10.2147/IJWH.S37254.
